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We have shown that the total number of different medications 
people in the UK Biobank currently use has a polygenic 
architecture.
We identified 57 independent quantitative trait loci for 
medication-use, and showed that 14% of the phenotypic 
variation was explained by common genetic variants.
Medication-use had positive genetic correlation with heart 
diseases, and was negatively correlated with parents age of 
death and years in school.
The genetic architecture of medication-use is complex, and is
not solely driven by common diseases, as indicated by the 
strong negative genetic correlation.
To investigate the genetic architecture and biological 
mechanisms underlying medication-use in the general 
population.
Previously, Wu et al (2019) performed a genetic analysis in the 
UK Biobank on medication-use of 23 medication categories. 
Here, we extend on these results by investigating medication-
use, defined as the total number of different medications 
currently being used. We do this by performing a GWAS, 
heritability estimates and genetic correlation analysis. 
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DATA & METHODS
From the UK Biobank we extracted information on medication-
use from n=335.744 unrelate white-British individuals 
(approval ID 31269) 
Medication-use was defined as the total number of different 
medications currently being used by the participants.
Medication-use Genetic analysis of medication-use
For the genetic analyses we used ~9 million imputed common 
genetic variants.
We performed the following analyses:
- Genome-wide association study (by PLINK [REF])
- Genetic correlations (by LD Hub [REF])
- Heritability estimation and partitioning (by SumHer [REF])
- Generic scores (by R-qgg [REF])
3,337 different medications are currently being used.
Top-used drugs (used by 18,000-66,000 individuals) are for;
- heart failure and hypertension (ramipril, bendroflumethiazide)
- lowering colesterol (simvastatin)
- stomach ulcer (omeprazole)
- painkillers and fever lowering (aspirin, ibuprofen, paracetamol)
RESULTS-I
We identified 57 independent genetic loci showing statistical association with medication-use.
Parents age at death
Years of schooling 2016














Estimated genetic correlations 
showed that medication-use was 
positively correlated with common 
diseases, smoking and depressive 
symptoms; and was negatively
correlated with years in school and 
age of parents death.
RESULTS-II








































































































































































The heritability of 
medication-use was 
estimated to 0.14, with 
equal contribution from 
each autosomal 
chromosomes, with 
some genomic regions 
highly enriched.
Decomposing heritability Predicting medication-use


































































































After applying linkage 
disequilibrium pruning of the 
genetic variants (r2<0.7) the 
maximum prediction accuracy 
was obtained when including 
genetic markers with P-values 
< 0.2 (by five-fold cross 
validation).
Dividing participants into 
percentiles according to 
their genertic scores, and 
estimate their effect size 
on medication-use, the 
5% with highest genetic 
load, used on average 
1.8 more drugs than the 
bottom distribution.
CONCLUSION
Our results demonstrate that medication-use per se is a 
complex trait irrespectively of medical condition.
The finding that current medication-use was strongly 
correlated with smoking behaviour, parents age of death, 
educational level and insomnia, suggest that the genetic 
architecture of medication-use is not biased towards major 
common diseases.
Understanding the genetic aetiology of complex diseases has 
been suggested as the route for improving medical treatment. 
However, when current medication-use, across medical 
conditions, appears to have a polygenic architecture, it might 
be inadequate to solely rely on analyses of complex diseases 
for improving medical treatment.
Thus, medication-use, or better medication response, is likely 
to be yet another puzzle piece in understanding complex 
human diseases, and for providing better medical
treatment for future generations.
Study summary Perspective
Grant number: R287-2018-735
Findings from this study;
… 57 independent quantitative trait loci for medication-use.
… 14% of the total variation in medication-use in UKBB is 
explained by common genetic variants.
… coding and conserved regions are heavily enriched by     
genetic variation for medication-use.
… positive genetic correlation with heart disease, diabetes, 
depression, insomnia and smoking. 
….negative genetic correlated with parents age of death 
and years in school.
… mean prediction accuracy of medication-use was 0.14.
… individuals with top 5% genetic load used ~1.8 more 
drugs than the bottom distribution.
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